About The Column Group
The Column Group was established in 2007 in San Francisco, United States, as an early-stage venture capital firm. Investments are directed toward life science startups in sectors including BioPharma and Therapeutics, with operations centered in the US. Portfolio companies such as Peloton Therapeutics, Aragon Pharmaceuticals, Flexus BioScience, and Revolution Medicines have been supported. Focus remains on innovative therapeutic and pharmaceutical developments.
- Headquarter San Francisco, United States
- Founders Peter Svennilson
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
The Acacia Group
& 1 more
-
Employee Count
Not available
-
Acquired by
Parabellum Investments
(May 18, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of The Column Group
Unlock access to complete
Funding Insights of The Column Group
Detailed funding history for The Column Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in The Column Group
The Column Group has secured backing from 2 investors. Prominent investors backing the company include The Acacia Group and Parabellum Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Parabellum Investments is operated as a global family office.
|
Locked | Locked | Locked |
Investor details for The Column Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by The Column Group
Investment portfolio details for The Column Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - The Column Group
Detailed financials for The Column Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
The Column Group Comparisons
Peer comparison for The Column Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of The Column Group
Detailed competitors of The Column Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on The Column Group
Complete news archive for The Column Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about The Column Group
The Column Group was founded in 2007.
The Column Group is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
The Column Group was established in 2007 in San Francisco, United States, as an early-stage venture capital firm. Investments are directed toward life science startups in sectors including BioPharma and Therapeutics, with operations centered in the US. Portfolio companies such as Peloton Therapeutics, Aragon Pharmaceuticals, Flexus BioScience, and Revolution Medicines have been supported. Focus remains on innovative therapeutic and pharmaceutical developments.
The Column Group has 2 investors. Key investors include The Acacia Group, and Parabellum Investments.